Intercept Pharmaceuticals | ICPT - Текущие обязательства



Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amarin USD 164.2M 15.45M 2026-06
Amgen USD 25.5B 547M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Galectin Therapeutics USD 14.62M 1.98M 2024-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Moderna USD 2.53B 139M 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novartis USD 31.75B 374M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06